Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy

Kidney International

Volumn 65, Issue 6, 2004, Pages 2409-2418

  Sijpkens, Yvo W ^a   Joosten, Simone A ^b   Wong, Man Chi ^b   Dekker, Friedo W ^b   Benediktsson, Hallgrimur ^b   Bajema, Ingeborg M ^b   Bruijn, Jan A ^b   Paul, Leendert C ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

C4d; Chronic rejection; Kidney transplantation; Risk factors; Transplant glomerulopathy

Indexed keywords

COMPLEMENT COMPONENT C4D; CYCLOSPORIN; HLA ANTIBODY; PARAFFIN; POLYCLONAL ANTIBODY;

ADULT; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; FEMALE; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; HLA SYSTEM; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGY; KIDNEY BIOPSY; MALE; MICROSCOPY; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; STAINING;

EID: 2442643785     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00662.x     Document Type: Article

References (32)

1. MARYNIAK RK, FIRST MR, WEISS MA: Transplant glomerulopathy: Evolution of morphologically distinct changes. Kidney Int 27:799-806, 1985
2. HABIB R, ZUROWSKA A, HINGLAIS N, et al: A specific glomerular lesion of the graft: Allograft glomerulopathy. Kidney Int 44(Suppl 42):S104-S111, 1993
3. SURI DL, TOMLANOVICH SJ, OLSON JL, MEYER TW: Transplant glomerulopathy as a cause of late graft loss. Am J Kidney Dis 35:674-680, 2000
4. RACUSEN LC, SOLEZ K, COLVIN RB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723, 1999
5. HALLORAN PF: Call for revolution: A new approach to describing allograft deterioration. Am J Transplant 2:195-200, 2002
6. ANDRESDOTTIR MB, ASSMANN KJ, KOENE RA, WETZELS JF: Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Am J Kidney Dis 32:582-588, 1998
7. GOUGH J, YILMAZ A, MISKULIN D, et al: Peritubular capillary basement membrane reduplication in allografts and native kidney disease: A clinicopathologic study of 278 consecutive renal specimens. Transplantation 71:1390-1393, 2001
8. HABIB R, BROYER M: Clinical significance of allograft glomerulopathy. Kidney Int 44 (Suppl 43):S95-S98, 1993
9. MAUIYYEDI S, COLVIN RB: Humoral rejection in kidney transplantation: New concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 11:609-618, 2002
10. RACUSEN L, COLVIN R, SOLEZ K, et al: Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 3:708-714, 2003
11. MAUIYYEDI S, PELLE PD, SAIDMAN S, et al: Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12:574-582, 2001
12. REGELE H, BOHMIG GA, HABICHT A, et al: Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 13:2371-2380, 2002
13. REGELE H, EXNER M, WATSCHINGER B, et al: Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 16:2058-2066, 2001
14. SIJPKENS YW, MALLAT MJ, SIEGERT CE, et al: Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral. Clin Nephrol 55:149-155, 2001
15. CRUZADO JM, CARRERA M, TORRAS J, GRINYO JM: Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 1:171-178, 2001
16. MESSIAS NC, EUSTACE JA, ZACHARY AA, et al: Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 72:655-660, 2001
17. SIJPKENS YW, DOXIADIS II, DE FIJTER JW, et al: Sharing cross-reactive groups of MHC class I improves long-term graft survival. Kidney Int 56:1920-1927, 1999
18. FURNESS PN, TAUB N: International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project. Kidney Int 60:1998-2012, 2001
19. SIJPKENS YWJ, DOXIADIS IIN, VAN KEMENADE FJ, et al: Chronic rejection with or without transplant vasculopathy. Clin Transplant 17:163-170, 2003
20. BONSIB SM, ABUL-EZZ SR, AHMAD I, et al: Acute rejection-associated tubular basement membrane defects and chronic allograft nephropathy. Kidney Int 58:2206-2214, 2000
21. CRESPO M, PASCUAL M, TOLKOFF-RUBIN N, et al: Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 71:652-658, 2001
22. TAKEMOTO SK, CHO YW, GJERTSON DW: Transplant risks. Clin Transpl 325-334, 1999
23. SIJPKENS YW, DOXIADIS II, MALLAT MJ, et al: Early versus late acute rejection episodes in renal transplantation. Transplantation 75:204-208, 2003
24. SAYEGH MH: Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 56:1967-1979, 1999
25. JOOSTEN SA, VAN DIXHOORN MG, BORRIAS MC, et al: Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol 160:1301-1310, 2002
26. THERUVATH TP, SAIDMAN SL, MAUIYYEDI S, et al: Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 72:77-83, 2001
27. OJO AO, MEIER-KRIESCHE HU, HANSON JA, et al: Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69:2405-2409, 2000
28. MEIER-KRIESCHE HU, STEFFEN BJ, HOCHBERG AM, et al: Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection. Am J Transplant 3:68-73, 2003
29. SHIIGAI T, SHICHIRI M: Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease. Am J Kidney Dis 37:477-183, 2001
30. RUGGENENTI P, PERNA A, REMUZZI G: ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: A post hoc analysis of the REIN trial results. Ramipril efficacy in nephropathy. J Am Soc Nephrol 12:2832-2837, 2001
31. HOLGADO R, ANAYA F, DEL CASTILLO D: Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation. Nephrol Dial Transplant 16 (Suppl 1):117-120, 2001
32. LIN J, VALERI AM, MARKOWITZ GS, et al: Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 73:783-788, 2002